2012臺灣精神醫學Requires access

Mirtazapine for Treatment of Drug-Resistant Pathological Skin Picking

Bor-Shien Kuo, Chia-Hung Tang, Tzu‐Yun Wang, Carol Sheei‐Meei Wang, Hong-Chen Yeh

Open publisher page 0 citations

Abstract

Objective: Pathological skin-picking (PSP) is a common disorder, and some pharmocotherapies for PSP have been reported. But the appropriate treatment is limited. We are reporting the use of mirtazapine to successfully treat a refractory PSP case. Case Report: This 42-year-old woman patient with mental retardation had suffered from treatment-refractory PSP for at least ten years. She had received behavioral therapies and various pharmacologic agents, including several kinds of antidepressants, topiramate, and lamotrigene. But she had got only minimal improvement. After receiving mirtazapine 30 mg/day for one week, the patient's PSP was dramatically improved. Conclusion: Mirtazapine showed to have improved PSP in this patient. More well-designed studies are needed to definitely prove the effect and neurobiologic actions of mirtazapine in PSP.

About this research paper

What this paper is about

Objective: Pathological skin-picking (PSP) is a common disorder, and some pharmocotherapies for PSP have been reported. But the appropriate treatment is limited. We are reporting the use of mirtazapine to successfully treat a refractory PSP case. Case Report: This 42-year-old woman patient with mental retardation had suffered from treatment-refractory PSP for at least ten years. She had received behavioral therapies and various pharmacologic agents, including several kinds of antidepressants, topiramate, and lamotrigene. But she had got only minimal improvement. After receiving mirtazapine 30 mg/day for one week, the patient's PSP was dramatically improved. Conclusion: Mirtazapine showed to have improved PSP in this patient. More well-designed studies are needed to definitely prove the effect and neurobiologic actions of mirtazapine in PSP.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: Pathological skin-picking (PSP) is a common disorder, and some pharmocotherapies for PSP have been reported. But the appropriate treatment is limited. We are reporting the use of mirtazapine to successfully treat a refractory PSP case. Case Report: This 42-year-old woman patient with mental retardation had suffered from treatment-refractory PSP for at least ten years. She had received behavioral therapies and various pharmacologic agents, including several kinds of antidepressants, topiramate, and lamotrigene. But she had got only minimal improvement. After receiving mirtazapine 30 mg/day for one week, the patient's PSP was dramatically improved. Conclusion: Mirtazapine showed to have improved PSP in this patient. More well-designed studies are needed to definitely prove the effect and neurobiologic actions of mirtazapine in PSP.

Key concepts: Mirtazapine, Topiramate, Medicine, Pathological, Refractory (planetary science), Drug, Mianserin, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Mirtazapine for Treatment of Drug-Resistant Pathological Skin Picking — Research Paper | ScholarLens